Two companies have received approved for a generic of the 2.5 mg tablet of anticoagulant rivaroxaban, which is used to reduce ...

The Food and Drug Administration (FDA) has approved the first generics of Xarelto ® (rivaroxaban) 2.5mg. Xarelto 2.5mg is used, in combination with aspirin, to: Reduce the risk of major cardiovascular ...

The U.S. Food and Drug Administration (FDA) has released several important updates addressing new medication approvals and ...

The other (P-3) was a seventy-eight-year-old man with coronary-artery disease who was unusually resistant to the prothrombinopenic effects of coumarin anticoagulant drugs; this patient was ...

Many people worry about the side effects of anticoagulant drugs like Eliquis or warfarin, but they prevent far more problems than they cause when prescribed appropriately. Many more strokes are caused ...

In September, Akeso, a little-known Chinese biotech company founded nearly a decade ago shook up the biotech sector with its new lung cancer drug. Ivonescimab, the new drug, was found in a trial ...

Feb 25 (Reuters) - Nearly 87,000 Americans died from drug overdose in the United States in the 12-month period ending September 2024, a decline of about 24% from the previous year, according to ...

Data remain inconclusive regarding potential drug-drug interactions between oral anticoagulants and antiretroviral therapy. Apixaban is currently the most prescribed oral anticoagulant in the ...

Antiretroviral drugs are used to treat HIV infection. They work by blocking a stage of the virus's life cycle and, by doing so, prevent the virus from replicating. The drugs are organized into six ...

Subscribe to the Daily News Brief. Mexican authorities have been waging a deadly battle against drug cartels for nearly two decades, but with limited success. Thousands of Mexicans—including ...

Anti-factor XI drugs may prevent thrombosis without compromising physiological hemostasis. "These anticoagulants aim to address gaps not covered by DOACs," noted Isabelle Gouin-Thibault ...

Neurologist and research leader Jonathan Coutinho said, "We think these new drugs will give patients ... with the new treatment with oral anticoagulants (DOACs). In total, data was collected ...